A clearer reading
Acute Effects of Cannabigerol
Registry metadata, preparation and research links; registration is not proof of benefit.
Registration describes a study. It does not establish benefit, retail product efficacy, vendor quality or current recruitment availability.
NCT05257044 · CBG
- Registry status
- Completed — sponsor-reported
- Phase
- Phase 1
- Registry results
- No results tables posted in registry
- Study preparation
- CBG oral preparation compared with placebo in a crossover design.
- Population
- Adults in an acute-effects field study; see linked paper for analyzed sample and formulation.
- Registered enrollment
- 38 (actual)
- Lead sponsor
- Washington State University
- First posted
- 2022-02-25
- Registry last update posted
- 2026-06-02
- Sponsor status verified
- 2024-08
- Our source check
- 2026-10-25
Interpretation limit
Acute subjective measures in a selected sample do not establish treatment for a diagnosed anxiety disorder.
Read the related research in context.
Related paper coverage is separate from registry-posted results tables.
Related primary paperSuggest a source correction
Copy a note and share it with the person who sent this preview. This page does not send or store your note.